| Literature DB >> 30018327 |
Alexis Fenyi1, Audrey Coens1, Tracy Bellande1, Ronald Melki1, Luc Bousset2.
Abstract
α-synuclein fibrillar polymorphs, Tau and Aß 1-42 fibrillar assemblies have been shown to propagate, amplify and trigger the formation of protein deposits reminiscent of those present within the central nervous system of patients developing synucleinopathies, tauopathies and amyloid plaques after injection intracerebrally, intramuscularly, intraperitoneally or within the blood stream of model animals. They are thus hazardous and there is need for decontamination and inactivation procedures for laboratory surfaces and non-disposable material. We assessed the effectiveness of different reagents to clean and disassemble potentially pathogenic assemblies adsorbed on non-disposable materials in laboratories. We show that commercial detergents and SDS are way more suited to detach α-synuclein fibrillar polymorphs, Tau and Aß 1-42 fibrillar assemblies from contaminated surfaces and disassemble the fibrils than methods designed to decrease PrP prion infectivity. Our observations reveal that the choice of the most adapted cleaning procedure for one given protein assembly or fibrillar polymorph should integrate detergent's cleaning efficiency, material compatibility and capacity to dismantle assemblies. We provide an integrated representation where desorption and neutralization efficacy and surface compatibility are combined to facilitate the choice of the most adapted decontamination procedure. This representation, together with good laboratory practices, contributes to reducing potential health hazards associated to manipulating protein assemblies with prion-like properties.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30018327 PMCID: PMC6050226 DOI: 10.1038/s41598-018-28856-2
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Fibrillar assemblies and experimental setup (A–C) electron micrographs of fibrillar assemblies. α-Syn fibrillar polymorphs (A), Tau fibrillar assemblies 1N3R or 1N4R (B), and Aß1–42 peptide fibrils (C). Representative images of the different plates used throughout the present study after spotting and drying 4 droplets of α-Syn fibrils labeled with Atto 550 imaged in visible light and by fluorescence (D). Scale bar, 200 nm.
Figure 2Efficiency of different cleaning solutions to remove amyloid fibrillar assemblies from plastic, glass, aluminum and stainless steel surfaces. Quantification of the remaining Atto-550 labeled fibrillar α-Syn polymorph “fibrils” (A), “ribbons” (B), “fibrils-65” (C), “fibrils-91” (D), Tau 1N3R fibrils (E), Tau 1N4R fibrils (F) and Aß fibrils (G) spotted and dried on plastic (red), glass (green), aluminum (blue) and stainless steel (grey) surfaces, previously scraped with sandpaper, using a fluorescence imager after cleaning with the different solutions. Error bars represent standard error (SE) (n = 4 independent measurements) performed in quadruplicates.
Figure 3Quantitative assessment of the fraction of non-fibrillar Atto-550 labeled α-Syn, Tau and Aß in the different cleaning solutions. The fraction (%) of the α-Syn fibrillar polymorphs “fibrils” (A), “ribbons” (B), “fibrils-65” (C), “fibrils-91” (D), Tau 1N3R fibrils (E), Tau 1N4R fibrils (F) and Aß fibrils (G), that becomes soluble in the cleaning solution was determined following ultracentrifugation by measurement of the absorbance of fluorescently labeled protein in the supernatant fraction as described in the material and methods section. Error bars represent standard error (SE) (n = 4 independent measurements) performed in quadruplicates.
Figure 4Combined representation of the cleaning procedures desorption and neutralization efficacies and compatibility with the contaminated surfaces. This representation combines the desorption and fibrils disassembly efficiency of each experimental treatment and the compatibility of the treatment with the nature of the surfaces. Colors spanning from brown (high) to dark green (low) integrate the proportion of material remaining adsorbed and of fibrillar nature. Hatched boxes indicate that the treatment corrodes the surface.
Laboratory Standard Operating Procedures for fibrillar protein assemblies with prion-like properties.
| Recommendations: | ||
|---|---|---|
| Step | Do | Do NOT |
| General | Use appropriate personal protective equipment: | - Eat or drink in an environment where α-Syn fibrillar strains, Tau and Aß fibrillar assemblies are used |
| Purification | - Keep the concentration of α-Syn fibrillar strains, Tau and Aß fibrillar assemblies below 1 mM | - Concentrate α-Syn, Tau and Aß above 1 mM |
| Fibrillization | - Use the minimal amount of α-Syn fibrillar strains, Tau and Aß fibrillar assemblies needed for the experiment | - Sonicate in open containers. This generates aerosol containing α-Syn fibrillar strains, Tau and Aß fibrillar assemblies that conceivably might reach the brain through the olfactory epithelium or the gut following inhalation and swallowing. |
| Storage | - Keep fibrils in closed tubes and discard in biohazard container immediately after use. | - Do not dry any fibrillar assembly on any surfaces, as this renders them more resistant to detergent solubilization/inactivation. |
| Inactivation | - Inactivate samples and contaminated surfaces with 1% SDS or commercial inactivation solutions for 1 hours at room temperature | - Do not use MilliQ water, NaOH or Sodium Hypochlorite |
| Recommendations: | ||
| α-Syn fibrillar strains, Tau and Aß fibrillar assemblies waste | Inactivation | |
| Fibrillar strains and assemblies in solution | Dilute the solution 10 folds in inactivation solution | |
| Surfaces contaminated with fibrillar strains and assemblies | Immerse completely in inactivation solution | |